Lenasi H. Introductory Chapter: Microcirculation in Health and Disease. In: Microcirculation Revisited Edited by Helena L. Rijeka: IntechOpen; 2016: Ch. 1.
Guven G, Hilty MP, Ince C, Microcirculation. Physiology, pathophysiology, and clinical application. Blood Purif. 2020;49(1–2):143–50.
Article CAS PubMed Google Scholar
Fleischer S, Tavakol DN, Vunjak-Novakovic G. From arteries to capillaries: approaches to engineering human vasculature. Adv Funct Mater. 2020;30(37).
Johnson PC. Overview of microcirculation. In: Handbook of Physiology: Microcirculation Edited by Ronald F. Tuma WND, Klaus Ley 2nd edn. San Diego, CA: Academic Press; 2008.
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753–86.
Article CAS PubMed PubMed Central Google Scholar
Horton WB, Barrett EJ. Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease. Endocr Rev. 2021;42(1):29–55.
Barrett EJ, Liu Z, Khamaisi M, King GL, Klein R, Klein BEK, et al. Diabetic microvascular Disease: an endocrine Society Scientific statement. J Clin Endocrinol Metab. 2017;102(12):4343–410.
Article PubMed PubMed Central Google Scholar
Giacco F, Brownlee M. Oxidative stress and diabetic Complications. Circ Res. 2010;107(9):1058–70.
Article CAS PubMed PubMed Central Google Scholar
Brownlee M. Biochemistry and molecular cell biology of diabetic Complications. Nature. 2001;414(6865):813–20.
Article CAS PubMed Google Scholar
Brownlee M. The pathobiology of diabetic Complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25.
Article CAS PubMed Google Scholar
Schalkwijk CG, Stehouwer CDA. Methylglyoxal, a highly reactive dicarbonyl compound, in Diabetes, its vascular Complications, and other Age-Related Diseases. Physiol Rev. 2020;100(1):407–61.
Article CAS PubMed Google Scholar
Stratmann B. Dicarbonyl stress in Diabetic Vascular Disease. Int J Mol Sci 2022;23(11).
Takeda Y, Matoba K, Sekiguchi K, Nagai Y, Yokota T, Utsunomiya K et al. Endothelial dysfunction in Diabetes. In: Biomedicines vol. 8; 2020.
Tsilibary EC. Microvascular basement membranes in Diabetes Mellitus. J Pathol. 2003;200(4):537–46.
Article CAS PubMed Google Scholar
Khalilgharibi N, Mao Y. To form and function: on the role of basement membrane mechanics in tissue development, homeostasis and Disease. Open Biol. 2021;11(2):200360.
Article CAS PubMed PubMed Central Google Scholar
Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis G-A, Vogiatzi G, Papaioannou S et al. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. European Cardiology Review 2019;14(1):50–9. 2019.
Fadini GP, Albiero M, Bonora BM, Avogaro A. Angiogenic abnormalities in Diabetes Mellitus: mechanistic and clinical aspects. J Clin Endocrinol Metabolism. 2019;104(11):5431–44.
Li X, Weber NC, Cohn DM, Hollmann MW, DeVries JH, Hermanides J et al. Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis. J Clin Med. 2021;10(11).
Sena CM, Pereira AM, Seiça R. Endothelial dysfunction — a major mediator of diabetic vascular Disease. Biochimica et Biophysica Acta (BBA) - molecular basis of Disease. 2013;1832(12):2216–31.
Stehouwer CDA. Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences. Diabetes. 2018;67(9):1729–41.
Article CAS PubMed Google Scholar
Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and Disease. Pflügers Archiv - European Journal of Physiology. 2020;472(9):1273–98.
Article CAS PubMed PubMed Central Google Scholar
Bakker W, Eringa EC, Sipkema P, van Hinsbergh VWM. Endothelial dysfunction and Diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009;335(1):165–89.
Article CAS PubMed Google Scholar
Pragallapati S, Manyam R. Glucose transporter 1 in health and Disease. J Oral Maxillofac Pathol. 2019;23(3):443–9.
Article PubMed PubMed Central Google Scholar
Rawat A, Morrison BM. Metabolic transporters in the peripheral Nerve—What, where, and why? Neurotherapeutics. 2021;18(4):2185–99.
Article CAS PubMed PubMed Central Google Scholar
Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl. 2011;(120):S1–6.
Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular Diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Therapy. 2023;8(1):152.
Roy CS, Sherrington CS. On the regulation of the blood-supply of the brain. J Physiol. 1890;11(1–2):85–158.
Article CAS PubMed PubMed Central Google Scholar
Kadry H, Noorani B, Cucullo L. A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids and Barriers of the CNS. 2020;17(1):69.
Article PubMed PubMed Central Google Scholar
Erdener ŞE, Dalkara T. Small vessels are a big Problem in Neurodegeneration and Neuroprotection. Front Neurol. 2019;10.
Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia. 1997;21(1):2–21.
Article CAS PubMed Google Scholar
Li X, Cai Y, Zhang Z, Zhou J. Glial and vascular cell regulation of the blood-brain barrier in Diabetes. Diabetes Metab J. 2022;46(2):222–38.
Article PubMed PubMed Central Google Scholar
Garcia-Serrano AM, Duarte JMN. Brain metabolism alterations in type 2 Diabetes: what did we learn from Diet-Induced Diabetes models? Front Neurosci. 2020;14.
Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II Diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2003;74(1):70–6.
Article CAS PubMed PubMed Central Google Scholar
Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD. Increased blood-brain barrier permeability and altered tight junctions in experimental Diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia. 2007;50(1):202–11.
Article CAS PubMed Google Scholar
Díaz-Castro B, Robel S, Mishra A. Astrocyte endfeet in brain function and Pathology: open questions. Annu Rev Neurosci. 2023;46:101–21.
Min LJ, Mogi M, Shudou M, Jing F, Tsukuda K, Ohshima K, et al. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension. 2012;59(5):1079–88.
Article CAS PubMed Google Scholar
Gandhi GK, Ball KK, Cruz NF, Dienel GA. Hyperglycaemia and Diabetes impair gap junctional communication among astrocytes. ASN Neuro. 2010;2(2):e00030.
Article PubMed PubMed Central Google Scholar
Warmke N, Griffin KJ, Cubbon RM. Pericytes in diabetes-associated vascular Disease. J Diabetes Complications. 2016;30(8):1643–50.
Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005;7(4):452–64.
Article CAS PubMed PubMed Central Google Scholar
Patrick P, Price TO, Diogo AL, Sheibani N, Banks WA, Shah GN. Topiramate protects pericytes from glucotoxicity: role for mitochondrial CA VA in Cerebromicrovascular Disease in Diabetes. J Endocrinol Diabetes. 2015;2(2).
Ferland-McCollough D, Slater S, Richard J, Reni C, Mangialardi G. Pericytes, an overlooked player in vascular pathobiology. Pharmacol Ther. 2017;171:30–42.
Article CAS PubMed PubMed Central Google Scholar
Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel Disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483–97.
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and Dementia: a statement for healthcare professionals from the American heart association/american Stroke association. Stroke. 2011;42(9):2672–713.
Article PubMed PubMed Central Google Scholar
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel Disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.
Article PubMed PubMed Central Google Scholar
Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw F-E, et al. Neuroimaging standards for research into small vessel Disease–advances since 2013. Lancet Neurol. 2023;22(7):602–18.
Wang Z, Chen Q, Chen J, Yang N, Zheng K. Risk factors of cerebral small vessel Disease: a systematic review and meta-analysis. Med (Baltim). 2021;100(51):e28229.
Eriksson MI, Summanen P, Gordin D, Forsblom C, Shams S, Liebkind R et al. C
Comments (0)